SUBSTITUIERTE OXOPYRIDINDERIVATE

European patent · EP3319956 · In force

Register entry

Publication number
EP3319956
Application number
EP16734672
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 5, 2016
Published
May 16, 2018
Granted
Jan 6, 2021
Protection ends at the latest
Jul 4, 2036
Next annual fee due
Jul 31, 2027
IPC classes
C07D 401/14 (2006.01)
C07D 413/14 (2006.01)
C07D 401/10 (2006.01)
C07D 413/10 (2006.01)
A61K 31/4439 (2006.01)
A61P 9/00 (2006.01)
A61P 27/02 (2006.01)
Priority
EP 15176099 09.07.2015
EP 16157350 25.02.2016
PCT application
PCT/EP2016/065787 05.07.2016
PCT publication
WO2017/005725 12.01.2017
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  4. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  5. Aug 1, 2022

    Change

    Published in Swissreg on 01.08.2022

  6. Nov 17, 2021

    Change

    Published in Swissreg on 17.11.2021

  7. Jan 6, 2021

    Granted

    Published in Swissreg on 06.01.2021

Parties

Holder

Bayer Pharma Aktiengesellschaft

Müllerstrasse 178, 13353 Berlin, DE

Inventor

HILLISCH, Alexander

42651 Solingen, DE

MEIER, Katharina

40822 Mettmann, DE

RÖHRIG, Susanne

40724 Hilden, DE

ACKERSTAFF, Jens

40225 Düsseldorf, DE

TERSTEEGEN, Adrian

42111 Wuppertal, DE

ELLERBROCK, Pascal

40215 Düsseldorf, DE

JIMENEZ NUNEZ, Eloisa

79104 Freiburg im Breisgau, DE

LANG, Dieter

42553 Velbert, DE

MEIBOM, Daniel

42113 Wuppertal, DE

HEITMEIER, Stefan

42489 Wülfrath, DE

STAMPFUSS, Jan

40470 Düsseldorf, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.